Le Lézard
Classified in: Health
Subject: RCL

Advisory - Potential contamination of health products manufactured by Eco-Med Pharmaceuticals Inc. may pose health risks to Canadians


OTTAWA, ON, Aug. 25, 2021 /CNW/ -

Summary
Product: All health products manufactured by Eco-Med Pharmaceuticals Inc. This includes ultrasound gels, transmission and massage lotions as well as hand sanitizers and first aid antiseptics.
Issue: Products manufactured by Eco-Med Pharmaceuticals Inc. may be contaminated, which may pose a health risk to Canadians. Health Canada has suspended the company's licences to manufacture and sell health products based on potential safety issues.
What to do: If you have purchased health products manufactured by Eco-Med Pharmaceuticals Inc., stop using them immediately and discard them. Consult a health care professional if you have used any of these products and have health concerns. 

Issue
Health Canada, as a precaution, is advising Canadians to stop using and discard all products manufactured by Eco-Med Pharmaceuticals (ultrasound gels, transmission and massage lotions, hand sanitizers and first aid antiseptics) due to potential bacterial contamination with Burkholderia stabilis (B. stabilis).

Health Canada previously communicated the manufacturer's voluntary recall for certain lots of ultrasound gels as a result of this contamination. The Department is now expanding the list of impacted products to include all of the company's products because the source of the bacterial contamination is unknown and cannot be determined at this time. In addition, the Department is not able to determine if there are other potential risks or other bacterial contamination as Eco-Med has ceased all company operations.

B. stabilis is a member of a group of bacterial organisms called Burkholderia cepacia complex (Bcc) that are potentially highly virulent and multi-drug resistant. The effects of Bcc vary widely, ranging from no symptoms at all to serious infections. Bcc bloodstream infections may result in sepsis and death in some cases.

Patients - particularly those with compromised immune systems - experiencing an unusual or persistent infection on the skin or in the general area where the product was applied, or who are feeling unwell (e.g., have a fever and/or feel tired), should seek immediate medical attention.

Product List:

Medical Devices: massage lotions and ultrasound lotions

EcoGel 100

EcoGel 200

EcoGel 300

EcoLotion Transmission and Massage Lotion

Medelco Multi Purpose Ultrasound Gel

Red Medical Ultrasound Gel

 

Natural Health Products: hand sanitizers and first aid antiseptic

Prevent+ (NPN 80097875)

Prevent+ Foam Sanitizer (NPN 80102490)

Prevent+ Rubbing Alcohol; Rubbing Alcohol 70%; (NPN 80103917)

First Aid Antiseptic: Prevent+ Hydrogen Peroxide 3% USP; Hydrogen Peroxide 3% USP;

(NPN 80107321)

Action taken by Health Canada

Health Canada has suspended the company's Medical Device Establishment Licence, COVID-SL (natural health product site licence) and natural health product licences to ensure the establishment no longer manufactures or sells any health products based on potential health and safety risks to Canadians.

Health Canada will continue to monitor the situation and will take appropriate and timely action should new information become available. Health Canada will also communicate any new safety information to healthcare professionals and consumers.

Consumers are advised to:

Healthcare professionals are advised to:

SOURCE Health Canada


These press releases may also interest you

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...



News published on and distributed by: